4AOJ
Human TrkA in complex with the inhibitor AZ-23
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | ESRF BEAMLINE ID14-4 |
Synchrotron site | ESRF |
Beamline | ID14-4 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2005-11-02 |
Detector | ADSC CCD |
Spacegroup name | I 2 2 2 |
Unit cell lengths | 130.727, 158.419, 152.577 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 40.000 - 2.750 |
R-factor | 0.2207 |
Rwork | 0.220 |
R-free | 0.24217 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 1r0p |
RMSD bond length | 0.015 |
RMSD bond angle | 1.574 |
Data reduction software | MOSFLM |
Data scaling software | SCALA |
Phasing software | MOLREP |
Refinement software | REFMAC (5.5.0109) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 42.060 | 2.820 |
High resolution limit [Å] | 2.750 | 2.750 |
Rmerge | 0.070 | 0.380 |
Number of reflections | 41385 | |
<I/σ(I)> | 13 | 3 |
Completeness [%] | 99.9 | 100 |
Redundancy | 3.6 | 3.6 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 8 | HANGING DROP METHOD. 1 UL TRKA AT 10 MG/ML IN 10 MG/ML IN 20 MM TRIS PH 8.5, 0.1% CHAPS, 1MM TCEP, 8.7% GLYCEROL MIXED WITH 1 UL MOTHER LIQUOR CONTAINING 35% W/V GLYCEROL, 140 MM NA/K TARTRATE, 100 MM HEPES PH 8.0 SUPPLEMENTED WITH 40 MM ZINC CHLORIDE. |